Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis

Health and Quality of Life Outcomes

Volumn 8, Issue , 2010, Pages

  Harrison, Mark J ^a   Lunt, Mark ^a   Verstappen, Suzanne M M ^a   Watson, Kath D ^a   Bansback, Nick J ^b   Symmons, Deborah P M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; DISEASE SEVERITY; EUROQOL 5D; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT ASSESSMENT; QUALITY ADJUSTED LIFE YEAR; RHEUMATOID ARTHRITIS; SHORT FORM 6D; VALIDITY; ARTHRITIS; COST BENEFIT ANALYSIS; EVALUATION; FOLLOW UP; HEALTH CARE QUALITY; HOSPITALIZATION; LONGITUDINAL STUDY; METHODOLOGY; MIDDLE AGED; PSYCHOMETRY; QUESTIONNAIRE; SICKNESS IMPACT PROFILE;

ADULT; AGED; ARTHRITIS; COST-BENEFIT ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROCESS ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 77649111262     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-8-21     Document Type: Article

References (23)

1. Torrance GW. Measurement of health state utilities for economic appraisal: A review. J Health Econ 1986, 5:1-30. 10.1016/0167-6296(86)90020-2, 10311607.
2. National Institute for Health and Clinical Excellence A guide to NICE. London 2005, National Institute for Health and Clinical Excellence.
3. Sullivan SD, Lyles A, Luce B, Grigar J. AMCP guidance for submission of clinical and economic evaluation data to support formulary listing in U.S. health plans and pharmacy benefits management organizations. J Manag Care Pharm 2001, 7:272-282.
4. The EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990, 16:199-208. 10.1016/0168-8510(90)90421-9, 10109801, The EuroQol Group.
5. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002, 21:271-292. 10.1016/S0167-6296(01)00130-8, 11939242.
6. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483. 10.1097/00005650-199206000-00002, 1593914.
7. Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 1982, 9:789-793.
8. Bansback N, Marra C, Tsuchiya A, Anis A, Guh D, Hammond T, Brazier J. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:963-971. 10.1002/art.22885, 17665482.
9. Brazier J. Valuing health States for use in cost-effectiveness analysis. Pharmacoeconomics 2008, 26:769-779. 10.2165/00019053-200826090-00007, 18767897.
10. Amjadi SS, Maranian PM, Paulus HE, Kaplan RM, Ranganath VK, Furst DE, Khanna PP, Khanna D. Validating and Assessing the Sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in Patients with Early Aggressive Rheumatoid Arthritis. J Rheumatol 2009,
11. Verstappen SM, McCoy MJ, Roberts C, Dale NE, Hassell AB, Symmons DP. The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial. Ann Rheum Dis 2009,
12. Symmons D, Tricker K, Harrison M, Roberts C, Davis M, Dawes P, Hassell A, Knight S, Mulherin D, Scott DL. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs - results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) 2006, 45:558-565. 10.1093/rheumatology/kei169, 16263778.
13. Silman A, Symmons D, Scott DG, Griffiths I. British Society for Rheumatology Biologics Register. Ann Rheum Dis 2003, 62(Suppl 2):ii28-ii29. 1766752, 14532144.
14. Prevoo MLL, Vanthof MA, Kuper HH, Vanleeuwen MA, Vandeputte LBA, Vanriel PLCM. Modified Disease-Activity Scores That Include 28-Joint Counts - Development and Validation in A Prospective Longitudinal-Study of Patients with Rheumatoid-Arthritis. Arthritis Rheum 1995, 38:44-48. 10.1002/art.1780380107, 7818570.
15. Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol 2008, 35:592-602.
16. NICE Guide to the methods of technology appraisal. 2008, London, National Institute for Clinical Excellence, NICE.
17. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42:851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
18. Barton GR, Sach TH, Jenkinson C, Avery AJ, Doherty M, Muir KR. Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?. Health Qual Life Outcomes 2008, 6:51. 10.1186/1477-7525-6-51, 2490675, 18625052.
19. A review of studies mapping (or cross walking) from non-preference based measures of health to generic preference-based measures. , http://www.shef.ac.uk/scharr/sections/heds/discussion.html
20. Scott DL, Khoshaba B, Choy EH, Kingsley GH. Limited correlation between the Health Assessment Questionnaire (HAQ) and EuroQol in rheumatoid arthritis: questionable validity of deriving quality adjusted life years from HAQ. Ann Rheum Dis 2007,
21. Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP. The Validity and Responsiveness of Generic Utility Measures in Rheumatoid Arthritis: A Review. J Rheumatol 2008, 35:592-602.
22. Harrison MJ. An evaluation of a health status measure and two health utility measures in patients with inflammatory polyarthritis (PhD Thesis). PhD Thesis 2008, The University of Manchester.
23. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ5D) and disease specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 2005, 60:1571-1582. 10.1016/j.socscimed.2004.08.034, 15652688.